(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 72.96%2.37B | 45.37%2.53B | -6.40%2.7B | 12.05%7.34B | -38.06%1.35B | 68,500.00%1.37B | -35.28%1.74B | 70.44%2.89B | 132.41%6.55B | 678.85%2.17B |
Net income from continuing operations | 0.24%2.52B | 17.91%1.52B | 191.73%776M | 40.26%4.29B | -82.02%222M | 50.72%2.51B | 50.53%1.29B | 138.00%266M | 162.49%3.06B | 99.84%1.24B |
Operating gains losses | 698.08%311M | -288.10%-79M | -194.97%-151M | -56.57%294M | 136.71%145M | -115.57%-52M | 119.18%42M | -83.39%159M | 0.15%677M | -740.43%-395M |
Depreciation and amortization | 12.43%190M | 13.13%181M | 9.94%177M | 9.56%665M | 7.36%175M | 16.55%169M | 7.38%160M | 7.33%161M | 1.34%607M | 15.60%163M |
Remuneration paid in stock | 21.35%108M | 17.28%95M | 64.81%89M | 42.24%330M | 100.00%106M | 34.85%89M | 39.66%81M | -1.82%54M | 112.84%232M | 152.38%53M |
Remuneration paid in stock | 15.63%148M | 9.38%140M | 27.43%144M | 31.19%530M | 57.84%161M | 26.73%128M | 18.52%128M | 21.51%113M | 7.45%404M | 18.60%102M |
Deferred tax | -265.00%-73M | 167.35%33M | 89.71%-35M | -85.99%-478M | -527.27%-69M | 75.31%-20M | -196.08%-49M | -57.41%-340M | 42.25%-257M | 89.22%-11M |
Other non cashItems | ---- | ---- | ---- | -86.84%5M | 200.00%2M | ---- | ---- | ---- | -46.48%38M | -120.00%-2M |
Change In working capital | 43.68%-820M | 636.47%626M | -31.18%1.7B | -4.79%1.71B | -41.25%604M | 34.68%-1.46B | -94.91%85M | 86.73%2.48B | 567.29%1.8B | 329.46%1.03B |
-Change in receivables | 121.46%179M | 22.29%-645M | -217.09%-185M | -8.31%-1.33B | 35.38%176M | -244.63%-834M | -5.06%-830M | 148.47%158M | -22.55%-1.23B | -23.53%130M |
-Change in prepaid assets | -75.81%45M | 131.25%65M | -183.05%-98M | 171.43%155M | -71.50%59M | 176.54%186M | -66.40%-208M | 310.71%118M | -3,716.67%-217M | 404.88%207M |
-Change in other working capital | -29.21%-1.04B | 7.39%1.21B | -9.68%1.99B | -10.99%2.88B | -46.60%369M | 53.67%-808M | -56.56%1.12B | 28.81%2.2B | 156.13%3.24B | 204.86%691M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 72.96%2.37B | 45.37%2.53B | -6.40%2.7B | 12.05%7.34B | -38.06%1.35B | 68,500.00%1.37B | -35.28%1.74B | 70.44%2.89B | 132.41%6.55B | 678.85%2.17B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 90.91%-2M | 451.28%137M | -95.65%69M | 386.87%1.49B | -107.65%-39M | 97.20%-22M | 68.03%-39M | 1,410.74%1.59B | 48.10%-518M | 165.13%510M |
Net PPE purchase and sale | -8.45%-77M | -58.70%-146M | -47.73%-130M | -248.07%-345M | -117.87%-94M | 27.55%-71M | -6.98%-92M | 19.27%-88M | 176.64%233M | 620.79%526M |
Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Net investment purchase and sale | 56.25%75M | 450.00%297M | -87.05%218M | 348.37%1.83B | 386.67%43M | 106.77%48M | 550.00%54M | --1.68B | -249.90%-736M | -103.01%-15M |
Net other investing changes | --0 | -1,300.00%-14M | -111.11%-19M | 120.00%3M | 1,300.00%12M | -95.45%1M | 95.83%-1M | 25.00%-9M | ---15M | ---1M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 90.91%-2M | 451.28%137M | -95.65%69M | 386.87%1.49B | -107.65%-39M | 97.20%-22M | 68.03%-39M | 1,410.74%1.59B | 48.10%-518M | 165.13%510M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -20.25%-3.17B | -60.49%-1.97B | 130.60%784M | -81.93%-8.91B | -619.83%-2.49B | -31.67%-2.63B | 1.05%-1.23B | -19.78%-2.56B | -295.24%-4.9B | 9,680.00%479M |
Net issuance payments of debt | ---1.11B | --0 | 691.80%2.96B | -19.99%1.39B | --0 | --0 | --1.89B | 54.63%-500M | 265.34%1.74B | --2.84B |
Net common stock issuance | 33.18%-1.76B | 46.37%-1.66B | 13.67%-1.86B | -56.73%-10.38B | -6.19%-2.49B | -32.66%-2.64B | -150.12%-3.1B | -104.96%-2.15B | -3,961.96%-6.62B | -58,475.00%-2.34B |
Cash dividends paid | ---291M | ---295M | ---299M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Proceeds from stock option exercised by employees | -84.62%2M | -25.00%3M | -94.29%6M | 1,814.29%134M | --12M | 550.00%13M | 100.00%4M | 3,400.00%105M | 40.00%7M | --0 |
Net other financing activities | 140.00%2M | 47.83%-12M | -52.94%-26M | -145.83%-59M | 33.33%-14M | 54.55%-5M | -2,200.00%-23M | -288.89%-17M | 14.29%-24M | -250.00%-21M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -20.25%-3.17B | -60.49%-1.97B | 130.60%784M | -81.93%-8.91B | -619.83%-2.49B | -31.67%-2.63B | 1.05%-1.23B | -19.78%-2.56B | -295.24%-4.9B | 9,680.00%479M |
Net cash flow | ||||||||||
Beginning cash position | 11.61%16.33B | 10.53%15.66B | -0.95%12.14B | 9.85%12.25B | 47.31%13.33B | 23.28%14.63B | 33.98%14.17B | 9.85%12.25B | 5.39%11.15B | -22.44%9.05B |
Current changes in cash | 38.07%-794M | 47.15%696M | 85.94%3.56B | -106.94%-79M | -137.41%-1.18B | 53.92%-1.28B | -64.27%473M | 438.58%1.91B | 95.37%1.14B | 721.22%3.16B |
Effect of exchange rate changes | 1,340.91%273M | -106.67%-31M | -450.00%-28M | 7.50%-37M | -118.60%-8M | 43.59%-22M | 57.14%-15M | 188.89%8M | -207.69%-40M | 2,250.00%43M |
End cash Position | 18.63%15.81B | 11.61%16.33B | 10.53%15.66B | -0.95%12.14B | -0.95%12.14B | 47.31%13.33B | 23.28%14.63B | 33.98%14.17B | 9.85%12.25B | 9.85%12.25B |
Free cash from | 76.48%2.3B | 44.62%2.38B | -8.10%2.57B | 13.14%7B | -40.32%1.25B | 1,455.21%1.3B | -36.68%1.65B | 76.61%2.8B | 145.87%6.19B | 1,078.65%2.1B |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data